April 10-12, 2025
SpinaFX was honored to participate in the 33rd Interdisciplinary Research Conference on Injectable Osteoarticular Biomaterials and Bone Augmentation (GRIBOI), held at the Fairmont Banff Springs Hotel in Banff, Alberta, Canada.
At Booth #3, our team engaged with interventional spine and pain specialists, researchers, and industry leaders from around the globe. CEO Jeff Cambra, Head of Clinical Affairs Jodi Menezes, and Chairman and CMO Dr. Kieran Murphy were present to share insights and foster discussions on the future of spine care. This event also marked Jodi Menezes’ first on-site field presence with the company – a meaningful step in our continued growth and collaboration across the clinical landscape.
We are proud to have contributed to global conversations on the next generation of minimally invasive, image-guided treatments aimed at addressing the therapeutic gap in back pain management. Our esteemed medical advisors – including Dr. Douglas Beall, Dr. Olivier Clerk, Professor Alexis Kelekis, Dr. Dan Nguyen, Dr. Mohan Radhakrishna, Dr. Ana Mafalda Reis, Dr. Laszlo Kiss, Dr. Stefano Marcia, Dr. Jacob Fleming, Dr. Edward Yoon, Dr. Reade De Leacy, and Dr. Malin Nilsson – played a pivotal role in these discussions.
The collaborative spirit and exchange of ideas at GRIBOI 2025 have been instrumental in shaping the trajectory of spine care innovation. We extend our gratitude to all who visited our booth and participated in these meaningful conversations.
About SpinaFX
SpinaFX is a Canadian company focused on the development of image-guided, minimally invasive treatments for contained lumbar disc herniations. Through research partnerships, physician education, and thoughtful innovation, SpinaFX seeks to support clinicians in delivering meaningful care for patients affected by spinal conditions.